Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP416190.RA5hNEqdO2_d7QrmWEeL8MDAmyksCN9Ed0L36bf1B41RE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP416190.RA5hNEqdO2_d7QrmWEeL8MDAmyksCN9Ed0L36bf1B41RE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP416190.RA5hNEqdO2_d7QrmWEeL8MDAmyksCN9Ed0L36bf1B41RE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP416190.RA5hNEqdO2_d7QrmWEeL8MDAmyksCN9Ed0L36bf1B41RE130_provenance.
- NP416190.RA5hNEqdO2_d7QrmWEeL8MDAmyksCN9Ed0L36bf1B41RE130_assertion description "[In the present study, we investigated the levels of two major endocannabinoids, anandamide and 2-arachidonylglycerol (2-AG), and their receptors, CB1 and CB2, in human low grade glioma (WHO grade I-II) tissues, high grade glioma (WHO grade III-IV) tissues, and non-tumor brain tissue controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP416190.RA5hNEqdO2_d7QrmWEeL8MDAmyksCN9Ed0L36bf1B41RE130_provenance.
- NP416190.RA5hNEqdO2_d7QrmWEeL8MDAmyksCN9Ed0L36bf1B41RE130_assertion evidence source_evidence_literature NP416190.RA5hNEqdO2_d7QrmWEeL8MDAmyksCN9Ed0L36bf1B41RE130_provenance.
- NP416190.RA5hNEqdO2_d7QrmWEeL8MDAmyksCN9Ed0L36bf1B41RE130_assertion SIO_000772 22176552 NP416190.RA5hNEqdO2_d7QrmWEeL8MDAmyksCN9Ed0L36bf1B41RE130_provenance.
- NP416190.RA5hNEqdO2_d7QrmWEeL8MDAmyksCN9Ed0L36bf1B41RE130_assertion wasDerivedFrom befree-20140225 NP416190.RA5hNEqdO2_d7QrmWEeL8MDAmyksCN9Ed0L36bf1B41RE130_provenance.
- NP416190.RA5hNEqdO2_d7QrmWEeL8MDAmyksCN9Ed0L36bf1B41RE130_assertion wasGeneratedBy ECO_0000203 NP416190.RA5hNEqdO2_d7QrmWEeL8MDAmyksCN9Ed0L36bf1B41RE130_provenance.
- befree-20140225 importedOn "2014-02-25" NP416190.RA5hNEqdO2_d7QrmWEeL8MDAmyksCN9Ed0L36bf1B41RE130_provenance.